Dr. Sai Sudhakar Chennamsetty, MD

Dr. Chennamsetty practices at Our Lady of Lourdes Regional Medical Center in Lafayette, Louisiana, part of Franciscan Missionaries of Our Lady.

Dr. Chennamsetty's NPI, 1245593979, was assigned on June 18, 2012. Dr. Chennamsetty holds Louisiana license 207907.

Dr. Chennamsetty's primary practice is Our Lady of Lourdes Regional Medical Center, at 4801 Ambassador Caffery Parkway, Lafayette, LA 70508 in Lafayette Parish. The practice phone is (337) 470-2000.

Dr. Chennamsetty's primary practice is Our Lady of Lourdes Regional Medical Center in Lafayette, Louisiana, part of Franciscan Missionaries of Our Lady. Dr. Chennamsetty is also affiliated with Ochsner Lafayette General Medical Center. The medical group on file is Pediatric Group of Acadiana. Dmand AI also links Dr. Chennamsetty to 4 more hospitals, 5 medical groups, 2 group practices and clinics, 2 home health agencies and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chennamsetty practices, 11 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chennamsetty's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chennamsetty is licensed in Louisiana.

CMS data shows 7,515 Medicare services from Dr. Chennamsetty across 8 procedure codes in 2024, for 1,007 Medicare patients. Medicare paid $662,838 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,007 Medicare patients who saw Dr. Chennamsetty in 2024. The largest group is 75 to 84, with 366 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chennamsetty's median patient age at 70, with 50% women.

In 2024, Dr. Chennamsetty wrote 2,989 Medicare Part D claims for 767 patients. 91% of them were for generic drugs. CMS names the drug for 2,507 of them, across 53 drugs with 11 or more claims each, at $108,860 in total drug cost. In 2023, CMS named 2,466 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chennamsetty for performance year 2024, reported individually. Dr. Chennamsetty accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 43 general payments to Dr. Chennamsetty from 18 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $213.